IN2014MU00625A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00625A
IN2014MU00625A IN625MU2014A IN2014MU00625A IN 2014MU00625 A IN2014MU00625 A IN 2014MU00625A IN 625MU2014 A IN625MU2014 A IN 625MU2014A IN 2014MU00625 A IN2014MU00625 A IN 2014MU00625A
Authority
IN
India
Prior art keywords
relates
cytostatic
synthesis
preparation
present
Prior art date
Application number
Other languages
English (en)
Inventor
M V Ramana Dr M
S Lokhande Dr R
Ankita Laxman Mehta
Original Assignee
M V Ramana Dr M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M V Ramana Dr M filed Critical M V Ramana Dr M
Priority to IN625MU2014 priority Critical patent/IN2014MU00625A/en
Publication of IN2014MU00625A publication Critical patent/IN2014MU00625A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN625MU2014 2014-02-21 2014-02-21 IN2014MU00625A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN625MU2014 IN2014MU00625A (enExample) 2014-02-21 2014-02-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN625MU2014 IN2014MU00625A (enExample) 2014-02-21 2014-02-21

Publications (1)

Publication Number Publication Date
IN2014MU00625A true IN2014MU00625A (enExample) 2015-09-25

Family

ID=54394047

Family Applications (1)

Application Number Title Priority Date Filing Date
IN625MU2014 IN2014MU00625A (enExample) 2014-02-21 2014-02-21

Country Status (1)

Country Link
IN (1) IN2014MU00625A (enExample)

Similar Documents

Publication Publication Date Title
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
PH12017500507A1 (en) Cytotoxicity-inducing therapeutic agent
CY1123920T1 (el) Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου
GEP20217211B (en) Substituted carbonucleoside derivatives useful as anticancer agents
SA519410795B1 (ar) تخليق مشتقات فوسفات
SA519410320B1 (ar) مركبات فينيل -2-هيدروكسي-أسيتيل أمينو -2-ميثيل-فينيل
MX389515B (es) Proceso mejorado para producir fucoxantina y/o polisacáridos de microalgas.
JO3372B1 (ar) مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية
PH12016501613A1 (en) Pyrazines modulators of gpr6
WO2016061555A3 (en) Novel small molecule anticancer agents
PH12017500853A1 (en) Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases
TN2016000490A1 (en) Naphthyridinedione derivatives.
PL410329A1 (pl) Kompleksy rutenu, sposób ich wytwarzania oraz ich zastosowanie
NZ720106A (en) A process for the preparation of regadenoson
PH12016501997A1 (en) Cycloalkyl-linked diheterocycle derivatives
MX2016015298A (es) Inhibidores de nampt y metodos.
PH12017501955A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
PH12018500014A1 (en) Total synthesis of shishijimicin a and analogs thereof
IN2014MU00165A (enExample)
IN2014MU00625A (enExample)
MX2017008655A (es) Derivados de jasmonato y composiciones de los mismos.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
IN2013DE03665A (enExample)
IN2013MU04030A (enExample)